The burgeoning popularity of retatrutide, initially for blood sugar control , is creating significant interest within the UK , prompting a notable shift in medication trends. Obtaining these treatments remains a complex challenge , with National Health Service provision currently limited and independent providers offering therapy at a higher cost .